Santen Pharmaceutical Co Ltd - ESG Rating & Company Profile powered by AI
This page displays a zero-cost Environmental, Social and Governance analysis for Santen Pharmaceutical Co Ltd. Detailed Sustainability assessment of Santen Pharmaceutical Co Ltd are accessed by signing up for free. This ESG assessment for Santen Pharmaceutical Co Ltd indicates the company's transparency towards the UN Sustainable Development Goals.
Santen Pharmaceutical Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.6; made up of an environmental score of 6.7, social score of 5.7 and governance score of 1.3.
4.6
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 837 | Zentiva as | 4.7 | High |
| 837 | Zogenix Inc | 4.7 | High |
| 852 | Santen Pharmaceutical Co Ltd | 4.6 | High |
| 852 | Canopy Growth Corp | 4.6 | High |
| 852 | Novavax Inc | 4.6 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Santen Pharmaceutical Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Santen Pharmaceutical Co Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Santen Pharmaceutical Co Ltd report the average age of the workforce?
Sign up for free to unlockDoes Santen Pharmaceutical Co Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Santen Pharmaceutical Co Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Santen Pharmaceutical Co Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Santen Pharmaceutical Co Ltd offer flexible work?
Sign up for free to unlockDoes Santen Pharmaceutical Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Santen Pharmaceutical Co Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Santen Pharmaceutical Co Ltd conduct supply chain audits?
Sign up for free to unlockDoes Santen Pharmaceutical Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Santen Pharmaceutical Co Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Santen Pharmaceutical Co Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Santen Pharmaceutical Co Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Santen Pharmaceutical Co Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Santen Pharmaceutical Co Ltd disclose water use targets?
Sign up for free to unlockDoes Santen Pharmaceutical Co Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Santen Pharmaceutical Co Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Santen Pharmaceutical Co Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Santen Pharmaceutical Co Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Santen Pharmaceutical Co Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Santen Pharmaceutical Co Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Santen Pharmaceutical Co Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Santen Pharmaceutical Co Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Santen Pharmaceutical Co Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Santen Pharmaceutical Co Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Santen Pharmaceutical Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Santen Pharmaceutical Co Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Santen Pharmaceutical Co Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Santen Pharmaceutical Co Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Santen Pharmaceutical Co Ltd disclose its waste policy?
Sign up for free to unlockDoes Santen Pharmaceutical Co Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Santen Pharmaceutical Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Santen Pharmaceutical Co Ltd disclose energy use targets?
Sign up for free to unlockDoes Santen Pharmaceutical Co Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Santen Pharmaceutical Co Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Santen Pharmaceutical Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Santen Pharmaceutical Co., Ltd. researches and develops, manufactures, and markets pharmaceuticals and medical devices in Japan and internationally. It offers various pharmaceutical products to treat glaucoma and ocular hypertension, such as DE-111, which is in Phase III clinical trial; DE-117 in Japan; DE-126 that is in Phase IIb clinical trial; DE-128 in Europe, as well as is in Phase II/III clinical trial in the United States; and DE-130A that is in Phase III clinical trial. In addition, the company provides DE-114A to treat allergic conjunctivitis; DE-076C for the treatment of vernal keratoconjunctivitis; and DE-109, which is in Phase III clinical trial to treat uveitis. Further, it offers DE-127 to treat myopia, which is in Phase II/III clinical trial in Japan, as well as is in Phase III in Asia; DE-089C, which has completed Phase III clinical trials for the treatment of dry eye; and STN1013400, which is in Phase I clinical trials for the treatment of myopia. Additionally, the company offers over-the-counter pharmaceutical products. The company was formerly known as Santendo Pharmaceutical Co., Ltd. and changed its name to Santen Pharmaceutical Co., Ltd. in 1958. Santen Pharmaceutical Co., Ltd. was founded in 1890 and is headquartered in Osaka, Japan.